QR is out : net profit rose 11.54% to RM22.63 million for 1QFY2023, from RM20.29 million a year earlier, on the back of higher revenue amid increased sales to the prescription pharmaceutical market. Earnings per share improved to 2.38 sen, from 2.19 sen in 1QFY2022, Quarterly revenue grew 7.82% to RM200.48 million from RM185.94 million.
Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???
This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.
Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
I love astronomy so most of my calculation/logics actually somehow related to astrophysics and planetary orbit. Something to do with price resistance, time resistance and speed resistance.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
47,378 posts
Posted by pang72 > 2022-12-21 11:57 | Report Abuse
DPHARMA up too..
But, I don't hv..
Because glc link.
.